Page last updated: 2024-08-17

cysteamine and Non-alcoholic Fatty Liver Disease

cysteamine has been researched along with Non-alcoholic Fatty Liver Disease in 9 studies

Research

Authors	Studies
Behling, C; Fishbein, MH; Jain, AK; Lavine, JE; Miloh, T; Molleston, JP; Murray, KF; Newton, KP; Rosenthal, P; Schwimmer, JB; Vos, MB; Wilson, L	1
Kohli, R; Lin, CH	1
Alazraki, A; Brunt, EM; Doo, E; Hamilton, G; Heba, ER; Kleiner, DE; Lavine, JE; Masand, P; Middleton, MS; Schwimmer, JB; Shen, W; Sirlin, CB; Tonascia, J; Trout, AT; Van Natta, ML	1
Chalasani, N; Gawrieh, S	1
Besouw, M; Levtchenko, E; Masereeuw, R; van den Heuvel, L	1
Barlow, SE; Brunt, EM; Clark, JM; Doo, E; Jain, AK; Karpen, SJ; Kleiner, DE; Kohli, R; Lavine, JE; Molleston, JP; Murray, KF; Neuschwander-Tetri, BA; Rosenthal, P; Schwimmer, JB; Tonascia, J; Van Natta, ML; Vos, MB; Whitington, PF; Wilson, LA; Xanthakos, SA	1
Alkhouri, N; Feldstein, AE	1
Cabrera, BL; Dohil, R; Duke, KB; Durelle, J; Lavine, JE; Schmeltzer, S; Schwimmer, JB; Wang, T	1
Cabrera, BL; Dohil, R; Lavine, JE; Meyer, L; Phillips, SA; Schmeltzer, S	1

3 review(s) available for cysteamine and Non-alcoholic Fatty Liver Disease

Article	Year
Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease. Current gastroenterology reports, 2020, Aug-19, Volume: 22, Issue:10 Topics: Adolescent; Alanine Transaminase; Antioxidants; Bariatric Surgery; Child; Child, Preschool; Cysteamine; Cystine Depleting Agents; Delayed-Action Preparations; Diet; Humans; Hypoglycemic Agents; Infant; Infant, Newborn; Life Style; Liver Cirrhosis; Metformin; Non-alcoholic Fatty Liver Disease; Pediatric Obesity; Vitamin E	2020
Emerging Treatments for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Clinics in liver disease, 2018, Volume: 22, Issue:1 Topics: Antibodies, Monoclonal, Humanized; CCR5 Receptor Antagonists; Chalcones; Chenodeoxycholic Acid; Clinical Trials, Phase II as Topic; Cysteamine; Cystine Depleting Agents; Humans; Imidazoles; Incretins; Liraglutide; Non-alcoholic Fatty Liver Disease; Propionates; Protein Kinase Inhibitors; Randomized Controlled Trials as Topic; Sulfoxides	2018
Cysteamine: an old drug with new potential. Drug discovery today, 2013, Volume: 18, Issue:15-16 Topics: Animals; Cysteamine; Fatty Liver; Humans; Neurodegenerative Diseases; Non-alcoholic Fatty Liver Disease; Radiation-Protective Agents; Randomized Controlled Trials as Topic	2013

3 trial(s) available for cysteamine and Non-alcoholic Fatty Liver Disease

Article	Year
Alanine Aminotransferase and Gamma-Glutamyl Transpeptidase Predict Histologic Improvement in Pediatric Nonalcoholic Steatohepatitis. Hepatology (Baltimore, Md.), 2021, Volume: 73, Issue:3 Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Child; Cysteamine; Delayed-Action Preparations; Female; gamma-Glutamyltransferase; Humans; Liver; Male; Non-alcoholic Fatty Liver Disease; Predictive Value of Tests; Prognosis; Remission Induction; Treatment Outcome	2021
Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.), 2018, Volume: 67, Issue:3 Topics: Adolescent; Child; Cross-Sectional Studies; Cysteamine; Cystine Depleting Agents; Double-Blind Method; Female; Humans; Liver; Magnetic Resonance Imaging; Male; Non-alcoholic Fatty Liver Disease; Prospective Studies; Protons; Sensitivity and Specificity	2018
In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores. Gastroenterology, 2016, Volume: 151, Issue:6 Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Biopsy; Body Weight; Child; Cysteamine; Cystine Depleting Agents; Delayed-Action Preparations; Double-Blind Method; Female; Hepatitis; Humans; Intention to Treat Analysis; Liver; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Severity of Illness Index	2016

3 other study(ies) available for cysteamine and Non-alcoholic Fatty Liver Disease

Article	Year
Treating nonalcoholic steatohepatitis in children: Not a cinch task. Hepatology (Baltimore, Md.), 2017, Volume: 65, Issue:4 Topics: Adolescent; Antioxidants; Child; Cysteamine; Female; Humans; Liver; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress	2017
Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics, 2011, Volume: 33, Issue:9 Topics: Adiponectin; Adolescent; Antioxidants; Body Mass Index; Body Weight; Child; Cysteamine; Fatty Liver; Female; Humans; Insulin Resistance; Male; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Pilot Projects; Tablets, Enteric-Coated; Transaminases; Treatment Outcome	2011
The effect of cysteamine bitartrate on adiponectin multimerization in non-alcoholic fatty liver disease and healthy subjects. The Journal of pediatrics, 2012, Volume: 161, Issue:4 Topics: Adiponectin; Antioxidants; Child; Cysteamine; Dose-Response Relationship, Drug; Electrophoresis, Gel, Two-Dimensional; Fatty Liver; Humans; Non-alcoholic Fatty Liver Disease; Protein Multimerization	2012